These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19015657)

  • 1. Should cannabinoids be used as analgesics for neuropathic pain?
    Rice AS
    Nat Clin Pract Neurol; 2008 Dec; 4(12):654-5. PubMed ID: 19015657
    [No Abstract]   [Full Text] [Related]  

  • 2. New pain drugs in pipeline, but challenges to usage remain.
    Brower V
    J Natl Cancer Inst; 2012 Apr; 104(7):503-5. PubMed ID: 22440682
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabinoids for the treatment of neuropathic pain: clinical evidence.
    Ashton JC; Milligan ED
    Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuropathic pain. Basic principles for successful therapy].
    Tölle TR; Baron R
    MMW Fortschr Med; 2002 May; 144(21):41-4. PubMed ID: 12134424
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of cannabinoids in palliative medicine].
    Ernst G; Kongsgaard UE
    Tidsskr Nor Laegeforen; 2008 Apr; 128(7):822-5. PubMed ID: 18389029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids for neuropathic pain.
    Fine PG; Rosenfeld MJ
    Curr Pain Headache Rep; 2014 Oct; 18(10):451. PubMed ID: 25160710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What can we learn from failed neuropathic pain trials?
    Polydefkis M; Raja SN
    Neurology; 2008 Jan; 70(4):250-1. PubMed ID: 18209199
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain.
    Tanasescu R; Constantinescu CS
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1219-28. PubMed ID: 23621668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do cannabinoid drugs have a therapeutic value as analgesics?
    Whiteley NJ
    Prof Nurse; 2002 Sep; 18(1):51-3. PubMed ID: 12238727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are cannabinoids effective for orofacial pain states?
    Sessle BJ
    J Oral Facial Pain Headache; 2015; 29(1):5-6. PubMed ID: 25715439
    [No Abstract]   [Full Text] [Related]  

  • 11. Lacosamide for the treatment of diabetic neuropathic pain.
    Biton V
    Expert Rev Neurother; 2008 Nov; 8(11):1649-60. PubMed ID: 18986235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a definition of pharmacoresistant neuropathic pain.
    Hansson PT; Attal N; Baron R; Cruccu G
    Eur J Pain; 2009 May; 13(5):439-40. PubMed ID: 19324579
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing neuropathic pain with Sativex: a review of its pros and cons.
    Perez J; Ribera MV
    Expert Opin Pharmacother; 2008 May; 9(7):1189-95. PubMed ID: 18422475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do cannabinoids have a role in cancer pain management?
    Farquhar-Smith WP
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):7-13. PubMed ID: 19262386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cannabinoids as analgesics?].
    Keup W
    Med Monatsschr Pharm; 1998 Sep; 21(9):275-83. PubMed ID: 9770990
    [No Abstract]   [Full Text] [Related]  

  • 16. Miracle weed: cannabis can be a lifeline, and a fortunate few will soon get it on prescription.
    Wilson C
    New Sci; 2005 Feb 5-11; 185(2485):38-41. PubMed ID: 15839007
    [No Abstract]   [Full Text] [Related]  

  • 17. Management strategies for neuropathic pain in different European countries.
    Krajnik M; McCrory C; Allen S
    J Pain Palliat Care Pharmacother; 2007; 21(2):49-52. PubMed ID: 17844727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis derivatives and pain. A small role for delta9-tetrahydrocannabinol (THC) in some forms of multiple sclerosis.
    Prescrire Int; 2009 Oct; 18(103):226. PubMed ID: 19882800
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peripheral neuropathic pain relieved by somatosensory rehabilitation].
    Mathis F; Desfoux N; Sprumont P; Hecker E; Rossier P; Spicher C
    Rev Med Suisse; 2007 Nov; 3(135):2745-8. PubMed ID: 18214230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving early clinical drug development for neuropathic pain by improving patient selection.
    Segerdahl M
    Pain; 2009 Jan; 141(1-2):4-5. PubMed ID: 19084334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.